OMIX

Validation of a highly sensitive Sanger sequencing in detecting EGFR mutations from circulating tumor DNA in patients with lung cancers

OMIX001734

1Summary
Title Validation of a highly sensitive Sanger sequencing in detecting EGFR mutations from circulating tumor DNA in patients with lung cancers
Description This study aimed to evaluate the performance of the BDA Sanger method for the EGFR mutation detection in the ctDNA from lung cancer patients. A total of 195 plasma samples of lung cancer patients were included.
Organism Homo sapiens
Data Type Clinical Research data
Data Accessibility Open-access
BioProject PRJCA011591
Release Date 2024-09-27
Submitter Huiqin Jiang (jiang.huiqin@zs-hospital.sh.cn)
Organization Zhongshan Hospital, Fudan University
Submission Date 2022-09-01
2Files & Download

HTTP download speed may be slow. It is highly recommended that you download the dataset using a dedicated FTP tool (such as FileZilla Client).

File ID File Title Number/Samples File Type File Size File Suffix Download Times Download
OMIX001734-01 clinical data-BDA 195 Clinical Research data 81.5 KB xlsx 0

View All Released Data of OMIX